Introduction
Astenorm Total is a leading cardiac diabetes management tablet from Astemax Biotech, formulated as a triple therapy for effective glycemic control.
Composition
Each sustained-release (SR) tablet contains Gliclazide SR (typically 30-60 mg for insulin secretion), Metformin HCl SR (500-1000 mg for glucose reduction), and Pioglitazone (15-30 mg for insulin sensitivity).
Uses
It’s prescribed for type 2 diabetes, especially in patients with cardiovascular risks, to lower HbA1c, prevent complications like heart disease, and improve lipid profiles when monotherapy fails.
Benefits
This combo enhances insulin release, reduces hepatic glucose output, and boosts peripheral sensitivity for superior control over blood sugar and cardiac health markers
